MycoWorks is a biotech company that delivers commercially viable non-plastic and non-animal materials to the market.
MycoWorks is engaged in the creation of sustainable design solutions with advanced biomaterials. The company’s proprietary custom-engineered material is sustainable, versatile, and animal-free, and feels and performs like leather. Their first product, Reishi, and the proprietary platform to make it, Fine Mycelium, are a groundbreaking approach to biomaterials that delivers unparalleled versatility and unmatched performance in strength, durability, and hand feel. The perfect intersection of art and science, Reishi is the only natural material that performs like cowhide leather and is engineered to meet the highest quality standards.MycoWorks was founded by Sophia Wang and Philip Ross in 2013 and is based in Emeryville, California.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Oct 18, 2022 | Series C | — | 3 | General Motors Ventures | — | Detail |
Jan 12, 2022 | Series C | $125M | 3 | Prime Movers Lab | — | Detail |
Oct 13, 2020 | Series B | $45M | 18 | DCVC Bio WTT Investment | — | Detail |
Feb 25, 2020 | Series A | $17M | 8 | DCVC Bio | — | Detail |
May 8, 2019 | Series A | — | 2 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
General Motors Ventures | Yes | Series C |
Prime Movers Lab | Yes | Series C |
DCVC Bio | Yes | Series B |
WTT Investment | Yes | Series B |
IndieBio | — | Series C |
SOSV | — | Series C |
Mirabaud Asset Management | — | Series C |
SK Networks | — | Series C |
Gaingels | — | Series B |
10X Capital | — | Series B |